The effect of discontinuing hypertonic saline or dornase alfa on mucociliary clearance in elexacaftor/tezacaftor/ivacaftor treated people with cystic fibrosis: The SIMPLIFY-MCC Study
Scott H. Donaldson, Timothy E. Corcoran, Joseph M. Pilewski, Beth L. Laube, Peter J. Mogayzel, Agathe Ceppe, Jihong Wu, Kirby L. Zeman, Steven M. Rowe, David P. Nichols, Alex H. Gifford, William D. Bennett, Nicole Mayer-Hamblett
Topics & Concepts
IvacaftorMedicineCystic fibrosisDiscontinuationHypertonic salineMucociliary clearanceSubclinical infectionLungInternal medicineCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchTracheal and airway disorders